[1] Pan XF, Wang LM, Pan A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol, 2021; 9, 373−92. doi:  10.1016/S2213-8587(21)00045-0
[2] Wang YF, Zhao L, Gao LW, et al. Health policy and public health implications of obesity in China. Lancet Diabetes Endocrinol, 2021; 9, 446−61. doi:  10.1016/S2213-8587(21)00118-2
[3] Hu FB, Willett WC, Li T, et al. Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med, 2004; 351, 2694−703. doi:  10.1056/NEJMoa042135
[4] Wilson PWF, D'Agostino RB, Sullivan L, et al. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med, 2002; 162, 1867−72. doi:  10.1001/archinte.162.16.1867
[5] O'Hearn M, Liu JX, Cudhea F, et al. Coronavirus disease 2019 hospitalizations attributable to cardiometabolic conditions in the United States: a comparative risk assessment analysis. J Am Heart Assoc, 2021; 10, e019259.
[6] Li B, Yang J, Zhao FM, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol, 2020; 109, 531−8. doi:  10.1007/s00392-020-01626-9
[7] Masana L, Correig E, Ibarretxe D, et al. Low HDL and high triglycerides predict COVID-19 severity. Sci Rep, 2021; 11, 7217. doi:  10.1038/s41598-021-86747-5
[8] Ma Y, Zhu DS, Chen RB, et al. Association of overlapped and un-overlapped comorbidities with COVID-19 severity and treatment outcomes: a retrospective cohort study from nine provinces in China. Biomed Environ Sci, 2020; 33, 893−905.
[9] De Schutter A, Lavie CJ, Kachur S, et al. Body composition and mortality in a large cohort with preserved ejection fraction: untangling the obesity paradox. Mayo Clin Proc, 2014; 89, 1072−9. doi:  10.1016/j.mayocp.2014.04.025
[10] Dorner TE, Rieder A. Obesity paradox in elderly patients with cardiovascular diseases. Int J Cardiol, 2012; 155, 56−65. doi:  10.1016/j.ijcard.2011.01.076
[11] Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis. Ann Intern Med, 2013; 159, 758−69. doi:  10.7326/0003-4819-159-11-201312030-00008
[12] Park YMM, White AJ, Nichols HB, et al. The association between metabolic health, obesity phenotype and the risk of breast cancer. Int J Cancer, 2017; 140, 2657−66. doi:  10.1002/ijc.30684
[13] Tian QY, Wang AX, Zuo YT, et al. All-cause mortality in metabolically healthy individuals was not predicted by overweight and obesity. JCI Insight, 2020; 5, e136982. doi:  10.1172/jci.insight.136982
[14] Ndumele CE, Matsushita K, Lazo M, et al. Obesity and subtypes of incident cardiovascular disease. J Am Heart Assoc, 2016; 5, e003921.
[15] Gao M, Lv J, Yu CQ, et al. Metabolically healthy obesity, transition to unhealthy metabolic status, and vascular disease in Chinese adults: a cohort study. PLoS Med, 2020; 17, e1003351. doi:  10.1371/journal.pmed.1003351
[16] Mongraw-Chaffin M, Foster MC, Anderson CAM, et al. Metabolically healthy obesity, transition to metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol, 2018; 71, 1857−65. doi:  10.1016/j.jacc.2018.02.055
[17] Caleyachetty R, Thomas GN, Toulis KA, et al. Metabolically healthy obese and incident cardiovascular disease events among 3. 5 million men and women. J Am Coll Cardiol, 2017; 70, 1429−37. doi:  10.1016/j.jacc.2017.07.763
[18] Gallagher D, Visser M, Sepúlveda D, et al. How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? Am J Epidemiol, 1996; 143, 228-39.
[19] Xu T, Zhu G, Han SM. Trend of body compositions with aging among Chinese adolescents, adults and elders. J Nutr Health Aging, 2015; 19, 962−9. doi:  10.1007/s12603-015-0655-0
[20] Zhou BF. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults-study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci, 2002; 15, 83−96.
[21] Okorodudu DO, Jumean MF, Montori VM, et al. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes (Lond), 2010; 34, 791−9. doi:  10.1038/ijo.2010.5
[22] Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation, 2009; 120, 1640−5. doi:  10.1161/CIRCULATIONAHA.109.192644
[23] Yang XL, Li JX, Hu DS, et al. Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population: the China-PAR project (prediction for ASCVD risk in China). Circulation, 2016; 134, 1430−40. doi:  10.1161/CIRCULATIONAHA.116.022367
[24] Chinese Society of Cardiology of Chinese Medical Association, Cardiovascular Disease Prevention and Rehabilitation Committee of Chinese Association of Rehabilitation Medicine, Cardiovascular Disease Committee of Chinese Association of Gerontology and Geriatrics, et al. Chinese guideline on the primary prevention of cardiovascular diseases. Chin J Cardiol, 2020; 48, 1000−38. (In Chinese
[25] Max Gordon and Thomas Lumley. Forestplot: advanced forest plot using ‘grid’ graphics. R package version 1.10. 1. https://CRAN.R-project.org/package=forestplot. [2021-5-24].
[26] St-Onge MP, Janssen I, Heymsfield SB. Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual. Diabetes Care, 2004; 27, 2222−8. doi:  10.2337/diacare.27.9.2222
[27] Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. Natl Health Stat Report, 2009; 1−7.
[28] Adair KE, Padgett RN, von Waaden N, et al. Metabolic health, obesity, and cardiovascular disease, 2015-2016 national health and nutrition examination survey. Am J Med Sci, 2021; 361, 244−52. doi:  10.1016/j.amjms.2020.09.010
[29] Neeland IJ, Ross R, Després JP, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol, 2019; 7, 715−25. doi:  10.1016/S2213-8587(19)30084-1
[30] Ross R, Neeland IJ, Yamashita S, et al. Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. Nat Rev Endocrinol, 2020; 16, 177−89. doi:  10.1038/s41574-019-0310-7
[31] Feng TT, Vegard M, Strand LB, et al. Metabolically healthy obesity and risk for Atrial fibrillation: the HUNT study. Obesity (Silver Spring), 2019; 27, 332−8. doi:  10.1002/oby.22377
[32] Hamer M, Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab, 2012; 97, 2482−8. doi:  10.1210/jc.2011-3475
[33] Tian SM, Xu Y, Dong HM. The effect of metabolic health and obesity phenotypes on risk of hypertension: A nationwide population-based study using 5 representative definitions of metabolic health. Medicine (Baltimore), 2018; 97, e12425. doi:  10.1097/MD.0000000000012425
[34] Chang AR, Surapaneni A, Kirchner HL, et al. Metabolically healthy obesity and risk of kidney function decline. Obesity (Silver Spring), 2018; 26, 762−8. doi:  10.1002/oby.22134